News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,078 Results
Type
Article (86980)
Company Profile (704)
Press Release (766393)
Multimedia
Podcasts (152)
Webinars (19)
Section
Business (232868)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91134)
Employer Resources (199)
FDA (18208)
Job Trends (17372)
News (396949)
Policy (39838)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56976)
ALS (123)
Alzheimer's disease (1613)
Antibody-drug conjugate (ADC) (192)
Approvals (18161)
Artificial intelligence (407)
Autoimmune disease (39)
Automation (20)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (407)
Cancer (3201)
Cardiovascular disease (257)
Career advice (3542)
Career pathing (34)
CAR-T (213)
CDC (43)
Cell therapy (588)
Cervical cancer (25)
Clinical research (74475)
Collaboration (1152)
Company closure (3)
Compensation (733)
Complete response letters (38)
COVID-19 (2914)
CRISPR (70)
C-suite (386)
Cystic fibrosis (124)
Data (3247)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (384)
Diagnostics (6994)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (192)
Drug pricing (155)
Drug shortages (36)
Duchenne muscular dystrophy (160)
Earnings (97786)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131625)
Executive appointments (924)
FDA (20072)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (41)
Gene therapy (463)
GLP-1 (946)
Government (5284)
Grass and pollen (7)
Guidances (215)
Healthcare (20920)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (42)
Infectious disease (3119)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (129)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (601)
Leadership (27)
Legal (10138)
Liver cancer (85)
Longevity (12)
Lung cancer (448)
Lymphoma (224)
Machine learning (12)
Management (65)
Manufacturing (478)
MASH (104)
Medical device (14749)
Medtech (14755)
Mergers & acquisitions (22607)
Metabolic disorders (978)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2407)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (497)
Opinion (292)
Ovarian cancer (106)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (203)
Partnered (25)
Patents (338)
Patient recruitment (186)
Peanut (55)
People (65789)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22975)
Phase II (32336)
Phase III (24357)
Pipeline (1784)
Policy (252)
Postmarket research (3554)
Preclinical (10379)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (544)
Real estate (7402)
Recruiting (76)
Regulatory (27316)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (937)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (140)
Last 7 days (583)
Last 30 days (1993)
Last 365 days (33901)
2025 (19617)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50593)
Australia (8892)
California (8001)
Canada (2482)
China (741)
Colorado (342)
Connecticut (356)
Delaware (215)
Europe (116123)
Florida (1195)
Georgia (273)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (33)
Louisiana (19)
Maine (73)
Maryland (1129)
Massachusetts (6128)
Michigan (280)
Minnesota (500)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (86)
New Hampshire (74)
New Jersey (2246)
New Mexico (31)
New York (2234)
North Carolina (1267)
North Dakota (10)
Northern California (3470)
Ohio (259)
Oklahoma (17)
Oregon (48)
Pennsylvania (1714)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2977)
Tennessee (132)
Texas (1237)
United States (30196)
Utah (233)
Virginia (220)
Washington D.C. (80)
Washington State (704)
West Virginia (4)
Wisconsin (87)
There are 854,078 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sarepta Therapeutics to Announce Second Quarter 2025 Financial Results
July 31, 2025
·
1 min read
Press Releases
Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025
July 31, 2025
·
1 min read
Press Releases
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
July 31, 2025
·
1 min read
Press Releases
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development
July 31, 2025
·
3 min read
Press Releases
Cells: Hemostemix ACP-01 Provides the Scientific Basis for Improving the Longevity and Signal Uptake of Brain Computer Implants
July 31, 2025
·
10 min read
Press Releases
Envoy Medical Reports on Second Quarter 2025 Results
July 31, 2025
·
16 min read
Press Releases
Stem Cell Therapy Market Size to Lead USD 54.45 Billion by 2034 Driven by Advancements in Regenerative Medicine and Personalized Treatments
July 31, 2025
·
1 min read
Press Releases
U.S. mRNA Synthesis Raw Materials Market Size to Reach USD 1,161.26 Million By 2034
July 31, 2025
·
1 min read
Press Releases
Mitochondrial DNA Market to Reach USD 687.99 Million by 2034
July 31, 2025
·
1 min read
Regulatory
FDA Issued Myeloma, Alzheimer’s Approvals in July but Rejected Two CGTs
The FDA greenlit multiple new drugs this month and issued some notable label expansions including for Eli Lilly’s Kisunla. Meanwhile, the regulator turned away a cell therapy for Duchenne muscular dystrophy and a gene therapy for the rare disease Sanfilippo syndrome.
July 31, 2025
·
10 min read
·
Tristan Manalac
1 of 85,408
Next
